Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Fish and Richardson
Boehringer Ingelheim
Cipla
Deloitte
Queensland Health
Dow
McKesson
Fuji

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,791,111

« Back to Dashboard

Summary for Patent: 4,791,111
Title: [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]- 1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
Abstract:Novel [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H -imidazoles and 1H-1,2,4-triazoles, having anti-microbial activity, compositions containing the same, and methods of inhibiting and/or eliminating the development of fungi and bacteria in warm-blooded animals suffering from diseases caused by these fungi and/or bacteria.
Inventor(s): Heeres; Jan (Vosselaar, BE), Backx; Leo J. J. (Arendonk, BE), Thijssen; Jozef B. A. (Kasterlee, BE), Knaeps; Alfonsus G. (Herentals, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:06/919,400
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,791,111

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,791,111

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1292472 ➤ Try a Free Trial
Cyprus 1825 ➤ Try a Free Trial
European Patent Office 0228125 ➤ Try a Free Trial
Denmark 164167 ➤ Try a Free Trial
Ireland 59564 ➤ Try a Free Trial
Greece 3004114 ➤ Try a Free Trial
Finland 88505 ➤ Try a Free Trial
Hong Kong 46295 ➤ Try a Free Trial
Ireland 863369 ➤ Try a Free Trial
Finland 865257 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Chubb
Queensland Health
Federal Trade Commission
Boehringer Ingelheim
Daiichi Sankyo
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot